CD163 and Sepsis: In others reports, the expression of CD163 by monocytes is accurate for discriminating patients with inflammatory presentation from those with sepsis (33), suggesting that CD163 may be a biomarker of prognosis and that the expression of CD163 by monocytes is higher in non-survivors than in survivors (34).